Clinical Trial: A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07681479) titled 'A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants' on June 23.

Brief Summary: This study is a single-center, open-label, single-dose phase I clinical trial. The trial is divided into four periods: screening, baseline, treatment, and follow-up

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Fluid Retention Due to Heart Failure

Intervention: DRUG: [14C]HRS-9057

[14C]HRS-9057

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....